Ledger.Open graph →
SEC Form D · filed February 12, 2020

Solace Therapeutics Inc

Offering
$17.6M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
FRAMINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

William H. Gruber · Framingham, MAExec · DirectorBrian R. Smith · Framingham, MADirectorJohn R. Mcdonough · Framingham, MADirectorKevin G. Connors · Framingham, MADirectorLivya A. Antonacci · Bethesda, MDExec · DirectorRyan B. Hanks · Charlotte, NCDirectorDonna J. Wagner · Bethesda, MDDirectorNicolas Bonta · TORONTO, Ontario, CanadaDirectorGerrit R. Adams · Framingham, MADirectorJason Georgatos · Tiburon, CADirectorAndrew Kahn · Tiburon, CADirectorArmineh Baghoomian · Tiburon, CAExec · DirectorDan Feder · San Diego, CADirectorGerrit R. Adams · Framingham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗